Hinge Health Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Revenue	720.06	587.86	390.4	292.73
Revenue Growth	49.77%	50.58%	33.37%	-
Cost of Revenue	111.32	118.56	89.81	98.55
Gross Profit	608.75	469.3	300.59	194.18
Selling, General & Admin	385.67	646.46	230.97	214.64
Research & Development	129.07	368.14	100.84	110.06
Other Operating Expenses	0.34	1.08	-	-
Operating Expenses	515.07	1,016	331.81	324.69
Operating Income	93.67	-546.37	-31.22	-130.51
Interest & Investment Income	17.08	18.68	20.57	21.7
Other Non Operating Income (Expenses)	0.2	0.43	0.08	0.27
EBT Excluding Unusual Items	110.95	-527.26	-10.57	-108.55
Merger & Restructuring Charges	-	-	-0.69	-
Pretax Income	110.95	-527.26	-11.26	-108.55
Income Tax Expense	1.88	1	0.68	-0.41
Net Income	109.07	-528.26	-11.93	-108.14
Preferred Dividends & Other Adjustments	1.78	-104.17	-	-
Net Income to Common	107.29	-424.09	-11.93	-108.14
Net Income Growth	-	-	-	-
Shares Outstanding (Basic)	79	55	14	13
Shares Outstanding (Diluted)	81	55	14	13
Shares Change	267.86%	302.55%	4.16%	-
EPS (Basic)	1.36	-7.77	-0.88	-8.31
EPS (Diluted)	1.34	-7.77	-0.88	-8.31
EPS Growth	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Free Cash Flow	290.12	170.73	47.96	-65.89
Free Cash Flow Per Share	3.60	3.13	3.54	-5.06
Gross Margin	84.54%	79.83%	77.00%	66.33%
Operating Margin	13.01%	-92.94%	-8.00%	-44.59%
Profit Margin	14.90%	-72.14%	-3.06%	-36.94%
Free Cash Flow Margin	40.29%	29.04%	12.29%	-22.51%
EBITDA	95.69	-544.24	-28.87	-128.39
EBITDA Margin	13.29%	-92.58%	-7.40%	-43.86%
D&A For EBITDA	2.02	2.13	2.35	2.13
EBIT	93.67	-546.37	-31.22	-130.51
EBIT Margin	13.01%	-92.94%	-8.00%	-44.59%
Advertising Expenses	-	53.6	37.3	23.8

SEC Filings: 10-K · 10-Q